Effects of basic carbohydrate counting versus standard outpatient nutritional education (The BCC Study): study protocol for a randomised, parallel open-label, intervention study focusing on HbA1c and glucose variability in patients with type 2 diabetes

被引:6
|
作者
Ewers, Bettina [1 ]
Bruun, Jens Meldgaard [2 ,3 ]
Vilsboll, Tina [1 ,4 ]
机构
[1] Steno Diabet Ctr Copenhagen, Gentofte, Denmark
[2] Steno Diabet Ctr Aarhus, Aarhus, Denmark
[3] Univ Aarhus, Dept Clin Med, Aarhus, Denmark
[4] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
来源
BMJ OPEN | 2019年 / 9卷 / 11期
关键词
MANAGEMENT; LITERACY; NUMERACY; ADULTS; PREVENTION; CONSENSUS; THERAPY; SKILLS;
D O I
10.1136/bmjopen-2019-032893
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Recommendations on energy intake are key in body weight management to improve glycaemic control in people with type 2 diabetes (T2D). International clinical guidelines recommend a variety of eating patterns to promote energy restriction as the primary dietetic approach to body weight control in managing T2D. In addition, individualised guidance on self-monitoring carbohydrate intake to optimise meal timing and food choices (eg, basic carbohydrate counting (BCC)) is recommended to achieve glycaemic control. However, the evidence for this approach in T2D is limited. The objective of this study was to compare the effect of an educational programme in BCC as add-on to the usual dietary care on glycaemic control in people with T2D. Methods and analyses The study is designed as a randomised, controlled trial with a parallel-group design. The study duration is 12 months with data collection at baseline, and after 6 and 12 months. We plan to include 226 adults with T2D. Participants will be randomised to one of two interventions: (1) BCC as add-on to usual dietary care or (2) usual dietary care. The primary outcome is changes in glycated haemoglobin A1c or mean amplitude of glycaemic excursions from baseline and after 6-month intervention between and within study groups. Further outcome measures include changes in time in range, body weight and composition, lipid profile, blood pressure, mathematical literacy skills, carbohydrate estimation accuracy, dietary intake, diet-related quality of life, perceived competencies in diet and diabetes and perceptions of an autonomy supportive dietician-led climate, physical activity and urinary biomarkers.
引用
收藏
页数:9
相关论文
共 16 条
  • [1] Effects of basic carbohydrate counting versus standard dietary care for glycaemic control in type 2 diabetes (The BCC Study): a randomised, controlled trial
    Ewers, Bettina
    Blond, Martin B.
    Bruun, Jens M.
    Vilsboll, Tina
    NUTRITION & DIABETES, 2024, 14 (01):
  • [2] The dietary education trial in carbohydrate counting (DIET-CARB Study): study protocol for a randomised, parallel, open-label, intervention study comparing different approaches to dietary self-management in patients with type 1 diabetes
    Ewers, Bettina
    Vilsboll, Tina
    Andersen, Henrik Ullits
    Bruun, Jens Meldgaard
    BMJ OPEN, 2019, 9 (09):
  • [3] Effect of emerging digital technologies and methodologies combined with incentives on HbA1c in patients with type 2 diabetes mellitus: study protocol for a parallel, open randomized controlled trial
    Zhong, Shao
    Jiang, Jingyi
    Liu, Hongying
    Pan, Ying
    TRIALS, 2024, 25 (01)
  • [4] The Effect of a cognitive behavioral program based on an interactive application on serum glucose levels and HbA1C of family members of patients with type 2 diabetes: a study protocol for a randomized clinical trial
    Bahramnezhad, Fatemeh
    Jackson, Alun C.
    Ghorbani, Banafsheh
    Kahnouei, Mahmoud Shiri
    Sharifi, Farshad
    Negarandeh, Reza
    Salamat, Elaheh
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2023, 23 (2) : 2385 - 2393
  • [5] DAPagliflozin for the attenuation of albuminuria in Patients with hEaRt failure and type 2 diabetes (DAPPER study): a multicentre, randomised, open-label, parallel-group, standard treatment-controlled trial
    Yoshihara, Fumiki
    Imazu, Miki
    Sakuma, Ichiro
    Hiroi, Yukio
    Hara, Hisao
    Okazaki, Osamu
    Ishiguro, Chizuru
    Izumi, Chisato
    Noguchi, Teruo
    Shiraiwa, Toshihiko
    Nishioka, Norio
    Fujii, Kenshi
    Iwakura, Katsuomi
    Tomonaga, Osamu
    Kobayashi, Koichi
    Himi, Toshiharu
    Takihata, Masahiro
    Yumoto, Kazuhiko
    Takase, Hiroyuki
    Shimizu, Ikki
    Murakami, Tsutomu
    Wagatsuma, Kenji
    Sato, Katsuhiko
    Hiramatsu, Takeyuki
    Akabame, Satoshi
    Hata, Shiro
    Asakura, Masanori
    Kawabata, Takanori
    Omae, Katsuhiro
    Ito, Shin
    Kitakaze, Masafumi
    ECLINICALMEDICINE, 2023, 66
  • [6] Association of Long-Term HbA1c Variability with Anxiety and Depression in Patients with Type 2 Diabetes: A Cross-Sectional Retrospective Study
    Shi, Qian
    Ding, Jingcheng
    Su, Hong
    Du, Yijun
    Pan, Tianrong
    Zhong, Xing
    PSYCHOLOGY RESEARCH AND BEHAVIOR MANAGEMENT, 2023, 16 : 5053 - 5068
  • [7] Effects of Patient-Driven Lifestyle Modification Using Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: Results From the Randomized Open-label PDF Study
    Choe, Hun Jee
    Rhee, Eun-Jung
    Won, Jong Chul
    Park, Kyong Soo
    Lee, Won-Young
    Cho, Young Min
    DIABETES CARE, 2022, 45 (10) : 2224 - 2230
  • [8] Protocol of the adaptive study of IL-2 dose frequency on regulatory T cells in type 1 diabetes (DILfrequency): a mechanistic, non-randomised, repeat dose, open-label, response-adaptive study
    Truman, Lucy A.
    Pekalski, Marcin L.
    Kareclas, Paula
    Evangelou, Marina
    Walker, Neil M.
    Howlett, James
    Mander, Adrian P.
    Kennet, Jane
    Wicker, Linda S.
    Bond, Simon
    Todd, John A.
    Waldron-Lynch, Frank
    BMJ OPEN, 2015, 5 (12):
  • [9] Add-on imeglimin versus metformin dose escalation regarding glycemic control in patients with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: study protocol for a multicenter, prospective, randomized, open-label, parallel-group comparison study (MEGMI study)
    Nomoto, Hiroshi
    Takahashi, Akihiro
    Nakamura, Akinobu
    Kurihara, Hiroyoshi
    Takeuchi, Jun
    Nagai, So
    Taneda, Shinji
    Miya, Aika
    Kameda, Hiraku
    Cho, Kyu Yong
    Miyoshi, Hideaki
    Atsumi, Tatsuya
    BMJ OPEN DIABETES RESEARCH & CARE, 2022, 10 (06)
  • [10] Multicentre, open-label, randomised, parallel-group, superiority study to compare the efficacy of octreotide therapy 40 mg monthly versus standard of care in patients with refractory anaemia due to gastrointestinal bleeding from small bowel angiodysplasias: a protocol of the OCEAN trial
    Grooteman, K. V.
    van Geenen, E. J. M.
    Drenth, J. P. H.
    BMJ OPEN, 2016, 6 (09):